FDA
-
-
-
-
-
-
-
BioElectronics Corporation Chairman Richard Staelin, Ph.D., Updates Company Achievements
-
-
-
-
-
-
-
BioElectronics Files FDA 510(k) Application for Musculoskeletal Pain Complaints; Clinical Data Demonstrates Superior Drug Free Pain Relief to Prescription Strength NSAID Drug
-
-
-
-
-
-
-
BioElectronics President’s Response to Stock Price Decline
-
-
-
-
-
-
-
BioElectronics Receives FDA Pre-Submission Approval for its Post-Operation Pain Market Clearance Application
-
-
-
-
-
-
-
BioElectronics Announces the Launch of the ‘Try & Tell’ Program
-
-
-
-
-
-
-
BioElectronics Appoints an Indian Subcontinent Distributor
-
-
-
326,430 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

